Innovaccer Showcases the #1 Healthcare Data Platform at HIMSS22

2 years ago

HIMSS22 attendees will experience the company’s latest health cloud advancements and see how Innovaccer can help them accelerate their transformation…

Boosh Closes $1,007,400 In First Tranche Private Placement

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - March 10, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the…

Integrity Expands Retail Insurance Presence by Partnering with The Health Insurance Place

2 years ago

DALLAS, March 10, 2022 /PRNewswire/ -- Integrity Marketing Group, LLC ("Integrity"), an omnichannel insurtech leader in life, health and wealth solutions,…

IIOT-OXYS, Inc. Wins Contract Extension from a Major Northeast State’s DOT for Bridge Monitoring

2 years ago

CAMBRIDGE, MA / ACCESSWIRE / March 10, 2022 / IIOT-OXYS, Inc. (OTC PINK:ITOX) announced it has received approval for a…

MorphoSys AG Reports Non-Cash Impairment Charge of € 231 Million on Goodwill After Consolidation of Research and Discovery Functions; Corresponding Increase of Group Operating Expenses in 2021

2 years ago

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014PLANEGG and MUNICH, GERMANY…

IQAI’s Sponsored Phase I Clinical Trial is Open

2 years ago

MILWAUKEE, WI / ACCESSWIRE / March 10, 2022 / IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI) is pleased to announce that the sponsored…

Emerging Technology Insider Releases a New TechTalks Video Interview Featuring Richard T. Schumacher, CEO and Founder of Pressure BioSciences, Inc.

2 years ago

Discussions Centered on the Expanding Partnership Between Pressure BioSciences & The Ohio State University, the Food Industry Consortium, and the…

Medisafe Expands Executive Leadership to Support Continued Growth

2 years ago

New chief strategy officer, chief financial officer to drive business partnershipsBOSTON, MA / ACCESSWIRE / March 10, 2022 / Medisafe,…

Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate

2 years ago

Moderna's Omicron-specific bivalent booster candidate (mRNA-1273.214) combines Moderna's Omicron-specific booster candidate (mRNA-1273.529) and the Moderna COVID-19 vaccine (mRNA-1273)Moderna expects to…

Moderna to Host Third Annual Virtual Vaccines Day on March 24, 2022

2 years ago

CAMBRIDGE, MA / ACCESSWIRE / March 10, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…